Company Filing History:
Years Active: 2018-2019
Title: Joerg Huwyler: Innovator in Pharmaceutical Formulations
Introduction
Joerg Huwyler is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of delayed release technologies. With a total of 2 patents, Huwyler's work focuses on improving the delivery of active agents to the intestine, which is crucial for treating gastrointestinal disorders.
Latest Patents
Huwyler's latest patents include innovative formulations that enhance the effectiveness of pharmaceutical treatments. The first patent, titled "Delayed release pharmaceutical formulation and methods of making and using same," relates to a formulation designed to deliver an active agent specifically to the intestine. This invention outlines a method for preparing such formulations and their application in treating gastrointestinal disorders. The second patent, "Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting," further advances this concept by incorporating porous, functionalized calcium carbonate carrier particles. This formulation is also aimed at delivering active agents to the intestine, with a focus on colon targeting.
Career Highlights
Joerg Huwyler is associated with Tillotts Pharma AG, a company known for its commitment to developing innovative pharmaceutical solutions. His work at Tillotts Pharma AG has allowed him to focus on creating formulations that address specific medical needs, particularly in gastrointestinal health.
Collaborations
Huwyler collaborates with talented professionals in his field, including colleagues Daniel Preisig and Maxim Puchkov. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Joerg Huwyler's contributions to the field of pharmaceutical formulations demonstrate his commitment to improving healthcare solutions. His innovative patents and collaborations highlight the importance of research and development in addressing medical challenges.